does retatrutide vs Tirzepatide: Which Peptide Is More Effective for Fat Loss? Retatrutide: What It Is &

GSIS values were calculated by subtracting the insulin concentrations measured after incubation in the low-glucose buffer from those measured in the high-glucose buffer

Abstract Background Retatrutide, an agonist of glucose-dependent insulinotropic polypeptide, glucagon-like peptide-1, and glucagon receptors, is in development for the treatment of obesity

Drug designers are creating multi-agonists that stimulate more than one receptor, potentially amplifying results

Retrieved from Swanson S

Healthcare providers play a crucial role in individualizing treatment approaches based on patient characteristics, preferences, and therapeutic goals, thereby optimizing the benefits of injectable therapies in combating the dual burden of obesity and diabetes

By route of administration, the subcutaneous injection segment contributed the highest market share of 75% in 2025